Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Siva Nageswara Rao Gajula, Nimisha Nadimpalli & Rajesh Sonti. (2021) Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug Metabolism Reviews 53:3, pages 459-477.
Read now
Read now
T. Hansen, J. Borlak, A. Bader. (2000) Cytochrome P450 enzyme activity and protein expression in primary porcine enterocyte and hepatocyte cultures. Xenobiotica 30:1, pages 27-46.
Read now
Read now
M. J. Humphrey. (1996) Application of Metabolism and Pharmacokinetic Studies to the Drug Discovery Process. Drug Metabolism Reviews 28:3, pages 473-489.
Read now
Read now
J. A. Bell & M. H. Tarbit. (1992) Twenty years on: a review of the current practice of drug metabolism and pharmacokinetic studies in the pharmaceutical industry. Xenobiotica 22:7, pages 735-742.
Read now
Read now
Articles from other publishers (23)
ALA F. Nassar. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
303
322
.
ALA F. NASSAR. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
323
343
.
Chien-Ming Li, Jianjun Chen, Yan Lu, Ramesh Narayanan, Deanna N. Parke, Wei Li, Sunjoo Ahn, Duane D. Miller & James T. Dalton. (2011) Pharmacokinetic Optimization of 4-Substituted Methoxybenzoyl-aryl-thiazole and 2-Aryl-4-benzoyl-imidazole for Improving Oral Bioavailability. Drug Metabolism and Disposition 39:10, pages 1833-1839.
Crossref
Crossref
Ala F. Nassar. 2010. Biotransformation and Metabolite Elucidation of Xenobiotics. Biotransformation and Metabolite Elucidation of Xenobiotics
163
216
.
Myung Joo KANG, Woo Heon SONG, Byung Ho SHIM, Seung Youn OH, Hyun Young LEE, Eun Young CHUNG, Yesung SOHN & Jaehwi LEE. (2010) Pharmacologically Active Metabolites of Currently Marketed Drugs: Potential Resources for New Drug Discovery and Development. YAKUGAKU ZASSHI 130:10, pages 1325-1337.
Crossref
Crossref
Ala F. Nassar. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
13
.
Ala F. Nassar. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
16
.
Ala F. Nassar. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
269
281
.
Ala F. Nassar. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
253
268
.
Alaa-Eldin F. Nassar, Amin M. Kamel & Caroline Clarimont. (2004) Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability. Drug Discovery Today 9:23, pages 1020-1028.
Crossref
Crossref
Gary W. Caldwell, Zhengyin Yan, John A. Masucci, William Hageman, Gregory Leo & David M. Ritchie. (2012) Applied Pharmacokinetics in Drug Development. Pharmaceutical Development and Regulation 1:2, pages 117-132.
Crossref
Crossref
Srinivasu Poondru, Ralph E. Parchment, Vivek Purohit, Patricia LoRusso, Jerome P. Horwitz, Stuart T. Hazeldine, Lisa Polin, Thomas Corbett & Bhaskara R. Jasti. (2002) Lack of in Vitro – in Vivo Correlation of a Novel Investigational Anticancer Agent, SH 30. Investigational New Drugs 20:1, pages 23-33.
Crossref
Crossref
Thomas N. Thompson. (2001) Optimization of metabolic stability as a goal of modern drug design. Medicinal Research Reviews 21:5, pages 412-449.
Crossref
Crossref
Jack L. Segal MD, Keith C. Hayes, Sherry R. Brunnemann, Jane T. C. Hsieh, Patrick J. Potter, Mayank S. Pathak, David S. Tierney & David Mason. (2013) Absorption Characteristics of Sustained‐Release 4‐Aminopyridine (Fampridine SR) in Patients with Chronic Spinal Cord Injury. The Journal of Clinical Pharmacology 40:4, pages 402-409.
Crossref
Crossref
L. Williams, D. P. Hill, J. A. Davis & D. T. Lowenthal. (1996) The influence of food on the absorption and metabolism of drugs: an update. European Journal of Drug Metabolism and Pharmacokinetics 21:3, pages 201-211.
Crossref
Crossref
S.J. Barnett. (1996) A literature review looking at contemporary developments in antimicrobial agents, with special reference to applications in the field of podiatry. The Foot 6:2, pages 51-57.
Crossref
Crossref
Steven A. Wrighton, Barbara J. Ring & Mark Vandenbranden. (2016) The Use of In Vitro Metabolism Techniques in the Planning and Interpretation of Drug Safety Studies. Toxicologic Pathology 23:2, pages 199-208.
Crossref
Crossref
Mitchell N. Cayen. (2016) Considerations in the Design of Toxicokinetic Programs. Toxicologic Pathology 23:2, pages 148-157.
Crossref
Crossref
Anthony Y. H. Lu. 1995. Molecular Aspects of Oxidative Drug Metabolizing Enzymes. Molecular Aspects of Oxidative Drug Metabolizing Enzymes
503
513
.
Dennis A. Smith. (1994) Design of drugs through a consideration of drug metabolism and pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics 19:3, pages 193-199.
Crossref
Crossref
Alastair Monro. (1994) Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses. Journal of Pharmacokinetics and Biopharmaceutics 22:1, pages 41-57.
Crossref
Crossref
Manuel A. Navia & Debra A. Peattie. (1993) Structure-based drug design: applications in immunopharmacology and immunosuppression. Immunology Today 14:6, pages 296-302.
Crossref
Crossref
Manuel A. Navia & Debra A. Peattie. (1993) Structure-based drug design: applications in immunopharmacology and immunosuppression. Trends in Pharmacological Sciences 14:5, pages 189-195.
Crossref
Crossref